London, Oct. 11, 2022 (GLOBE NEWSWIRE) — Augmenting investments from both vaccine manufacturers, and governments are predominantly driving the growth of global vaccines market. In addition, greater emphasis on the various vaccination programs, and growing initiatives around public education and awareness about vaccines will further push the growth prospects of vaccines market. A new Fairfield Market Research report suggests that the market reached over US$33.3 Bn in 2020 and is likely to exceed the valuation of US$54.6 Bn toward the end of 2025. Between 2021 and 2025, global vaccines market value is expected to rise at a robust rate of 10.2%, says the report.
Constant efforts of the key manufacturers around innovative vaccine developments that would cover a broad range of disease indications will heighten the market growth outlook. Combination vaccines according to the report will also play out as a crucial driving force for the vaccines market.
Get the Free Sample Copy of Report at: https://www.fairfieldmarketresearch.com/report/vaccines-market/request-sample
Key Research Insights
- Global vaccines market is poised for more than 1.6x expansion in revenue during 2021 – 2025
- Shingles vaccine sales are likely to demonstrate notable growth of more than 15% through 2025
- The US, Canada, and the Americas are projected to account for around 50% of overall vaccines market value
Insights into Segmental Analysis
The report highlights pneumococcal conjugate vaccines as the…
